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Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is a member of the aldehyde dehydrogenase superfamily
and is involved with the metabolic processing of aldehydes. ALDH2 plays a cytoprotective role by removing
aldehydes produced during normal metabolism. We examined the cytoprotective role of ALDH2 speciﬁcally
in gastric mucosa cells. Overexpression of ALDH2 increased the viability of gastric mucosa cells treated with
H2O2, while knockdown of ALDH2 had an opposite effect. Moreover, overexpression of ALDH2 protected
gastric mucosa cells against oxidative stress-induced apoptosis as determined by ﬂow cytometry, Hoechst
33342, and TUNEL assays. Consistently, ALDH2 knockdown had an opposite effect. Additionally, DNA damage
was ameliorated in ALDH2-overexpressing gastric mucosa cells treated with H2O2. We further identiﬁed that
this cytoprotective role of ALDH2 was mediated by metabolism of 4-hydroxynonenal (4-HNE). Consistently,
4-HNE mimicked the oxidative stress induced by H2O2 in gastric mucosa cells. Treatment with 4-HNE in-
creased levels of DNA damage in ALDH2-knockdown GES-1 cells, while overexpression of ALDH2 decreased
4-HNE-induced DNA damage. These ﬁndings suggest that ALDH2 can protect gastric mucosa cells against
DNA damage caused by oxidative stress by reducing levels of 4-HNE.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Oxidative stress describes the oxidative damage caused by re-
active oxygen species (ROS) and represents the link between free
radicals and the diseases to which they contribute [1,2]. Inter-
mediates of oxygen reduction attack DNA, lipids, and proteins,
ultimately resulting in cellular damage. Cell membranes are very
sensitive to oxidative stress, and the methylene group between
two double bonds within a polyunsaturated fatty acid is especially
sensitive to oxidative damage [3].
Lipid peroxidation leads to the formation of reactive aldehydes
– predominantly 4-hydroxynonenal (4-HNE) – which exhibit high
reactivity with proteins and DNA [4,5]. As a highly toxic and stableInc. This is an open access article u
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ang),end-product of lipid peroxidation, 4-HNE contributes to the tissue
damage, dysfunction, injury and other pathological states that
occur with oxidative damage [6]. 4-HNE interacts with nucleic
acids to induce DNA damage and inﬂuences protein modiﬁcation
and cell signaling to ultimately perturb cellular metabolism [7].
4-HNE is a speciﬁc substrate of mitochondrial aldehyde dehy-
drogenase 2 (ALDH2) [8,9]. Human ALDH2 is a 517-amino acid
polypeptide encoded by a nuclear gene located at chromosome
12q24 and the protein is a tetrameric enzyme with 56-kDa iden-
tical subunits [10]. ALDH2 is a mitochondrial matrix protein that is
constitutively expressed in a variety of tissues including the liver,
kidney, heart, lung, and gastrointestinal tract. ALDH2 plays an
important role in oxidizing the endogenous aldehydic products –
such as 4-HNE – that arise from oxidative stress-induced lipid
peroxidation, thereby providing a protective function against these
toxic agents [11,12]. Consistently, activation of ALDH2 reduces is-
chemic damage to the heart by metabolizing the increased 4-HNE
that accumulates during cardiac ischemia [8]. ALDH2 also protects
against stroke by clearing 4-HNE, rendering the ALDH2 pathway a
potential target of therapeutic intervention in stroke [13].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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stress using a retrovirus-based system to both knock down and
overexpress ALDH2 in GES-1 gastric epithelial cells. Much research
regarding cell responses to oxidative stress has focused on the
inﬂuence of ROS, which, like the superoxide anions H2O2 and the
hydroxyl radical, form as a result of the incomplete reduction of
molecular oxygen [14]. Therefore, we treated GES-1 human gastric
mucosa cells with H2O2 to generate an oxidative stress model. We
then used this model to examine the effect of ALDH2 on DNA
damage induced by oxidative stress. Our investigation uncovers an
important role for ALDH2 in protecting the gastric mucosa from
oxidative damage.2. Materials and methods
2.1. Cell culture
GES-1-immortalized human gastric mucosa cells were cultured
in Roswell Park Memorial Institute 1640 medium supplemented
with 10% fetal bovine serum (FBS) in a humidiﬁed incubator (37 °C,
5% CO2) [15]. The human embryonic kidney cell line 293T was
preserved in our laboratory and maintained in Dulbecco’s mod-
iﬁed Eagle’s medium with 10% FBS at 37 °C in a humidiﬁed at-
mosphere with 5% CO2.
2.2. Lipid peroxidation
Lipid peroxidation was determined using the Biotech LPO-
586™ kit (Percipio Biosciences, Foster City, CA, USA) according to
the manufacturer’s instructions. GES-1 cells were treated with
H2O2 (Sangon Biotech, Shanghai, China) at required concentrations
for 6 h. For each determination, 5107 cells were collected by
centrifugation at 500 g for 10 min, washed twice, and re-
suspended in ice-cold phosphate-buffered saline (PBS). Standards
were prepared according to the manufacturer’s recommendation.
After cell lysis by sonication and homogenization, 650 μL of
N-methyl-2-phenylindole and 150 μL of methanesulfonic acid
were added to each sample, and the reaction mixture was vor-
texed and incubated at 45 °C for 60 min. The mixture was cen-
trifuged at 15,000 g for 10 min, and absorbance of the super-
natant at 586 nmwas measured. Values were expressed as nmol of
4-HNE/mg of protein.
2.3. Plasmids, shRNA designs and transfections
The full-length cDNA of ALDH2 (NM_000690.3) was obtained
by RT-PCR from the cDNA of human ALDH2 (GENECHEM, Shang-
hai, China). The cDNA was synthesized using the following pri-
mers: 5′-CGCGGATCCATGTTGCGCGCTGCCGCCCGCTTCG-3′ (for-
ward) and 5′-CCGGAATTCTTATGAGTTCTTCTGAGGCACTTTG-3′ (re-
verse). Primers were synthesized by Sangon Biotech (Shanghai,
China). After digestion with BamHI and EcoRI (Takara, Dalian,
China), the full-length cDNA of human ALDH2 was cloned and
inserted into pBABE-puro vector (Clontech Laboratories, Mountain
View, CA, USA).
Two pairs of complementary shRNA oligonucleotides targeting
ALDH2 and a pair of scrambled negative control shRNA oligonu-
cleotides were designed according to the Knockout™ RNAi Sys-
tems User Manual (Clontech Laboratories), annealed, and ligated
into RNAi-Ready pSIREN-RetroQ vector (Clontech Laboratories).
The target sequences for ALDH2 were 5′-ATGTCTCCGGTATTATGCC-
3′ (ALDH2-shRNA1) and 5′-TTATATCACCATTAAGGCA-3′ (ALDH2-
shRNA2). The sequence for scrambled negative control shRNA was
5′-ACTACCGTTGTTATAGGTG-3′. Proper insertion was conﬁrmed by
sequencing (BioSune, Shanghai, China). The retroviral packagingprocess was performed as previously described [16]. Brieﬂy, for
each 100-mm culture plate of 293T cells a plasmid mixture con-
taining 10 μg of retroviral vector, 10 μg of gag/pol vector, and 10 μg
of VSVG vector was incubated with 90 μL FuGENE9 transfection
reagent (Roche, Basel, Switzerland) in 600 μL of serum-free med-
ium. The plasmid/medium/FuGENE9 mixture was then added
drop-wise to a plate of 293T cells. After 12 h, 15 mL of viral col-
lection medium was added to the transfected cells. Infection of
GES-1 cells was performed in the presence of 5 μg/mL of poly-
brene (Sigma, MO, USA) in each well of a 6-well plate. Stable
retroviral transduction was achieved by infection for 48 h, after
which selection with puromycin (1 μg/mL) was initiated. Selection
was stopped as soon as non-infected control cells died, and the
media were replaced with standard culture media.
2.4. RNA isolation and qRT-PCR
Total RNA was isolated from cell lines using Trizol reagent
(Invitrogen™, Grand Island, NY, USA) according to the manu-
facturer’s instructions. Reverse transcription of 1 μg RNA was
carried out using M-MLV Reverse Transcriptase System (Promega,
Madison, WI, USA) following the manufacturer’s recommended
protocol. The expression level of ALDH2 mRNA was measured by
qRT-PCR using the SYBRs Green PCR Master Mix (Applied Bio-
systems, Foster City, CA, USA) according to the manufacturer’s
instructions. PCR reactions were performed using an ABI PRISM
7900 system (Perkin-Elmer, Torrance, CA, USA). Primers used for
ALDH2 (NM_000690.3) were: 5′-CCTCGGCTACATCAACACG-3′
(forward) and 5′-CCCAACAACCTCCTCTATGG-3′ (reverse). Primers
for GAPDH (NM_001289746) were: 5′-GGACCTGACCTGCCGTCTAG-
3′ (forward) and 5′-GTAGCCCAGGATGCCCTTGA-3′ (reverse). PCR
reactions involved a 5-min 95 °C initial denaturation step, 40 cy-
cles of denaturation at 95 °C for 10 s, annealing at 58 °C for 30 s,
and elongation at 72 °C for 30 s, then a ﬁnal extension at 72 °C for
10 min. Values for ALDH2 mRNA levels were normalized to those
of GAPDH. Each sample was measured in triplicate.
2.5. Cell viability assays
GES-1 cell proliferation was measured by the colorimetric
water-soluble tetrazolium salt (WST) assay with a Cell Counting
Kit-8 according to the manufacturer’s instructions (Dojindo, Ku-
mamoto, Japan). Cells were seeded on 96-well plates
(2103 cells/well) and treated with H2O2 or 4-HNE (Cayman, Ann
Arbor, MI, USA) at different concentrations for 6 h. Cell prolifera-
tion was then examined by determining the number of viable cells
based on measurement of the optical density difference between
450 nm and 600 nm using a Saﬁre2 microplate reader (Tecan,
Switzerland). All experiments were performed in triplicate.
For cell viability assessment, 3105 GES-1 cells/well were
seeded on a 6-well plate and grown overnight. Cells were treated
with 100 μMH2O2 for 6 h. Trypan blue exclusion staining was then
used to assess membrane damage during exposure to H2O2 as
described previously [17]. Cell viability was assessed using a cell
viability analyzer (Beckman Coulter, Brea, CA, USA). All experi-
ments were performed in triplicate.
2.6. Apoptosis analysis: ﬂow cytometry assay
GES-1 cells (3105 cells/well) were seeded on a 6-well plate
and grown overnight. Cells were treated with 100 μMH2O2 for 6 h,
collected by trypsinization, and then washed with PBS. Cells were
resuspended in binding buffer provided with the Annexin V-FITC
Apoptosis Detection Kit I (BD Pharmingen, San Jose, CA, USA) at a
concentration of 1106 cells/mL. Next, 2.5 μL of FITC Annexin V
and 5 μL propidium iodide (PI; BD Pharmingen) were added to
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dark at room temperature, 400 μL binding buffer was added.
Apoptosis was analyzed by ﬂow cytometry (FACSCalibur, Becton
Dickinson) using Cell Quest software (Becton Dickinson). Annexin
V-FITC-positive and PI-negative cells were classiﬁed as apoptotic.
2.7. Apoptosis analysis: Hoechst 33342 assay
To visualize nuclear morphological characteristics associated
with apoptosis, cells were washed in PBS and incubated with
Hoechst 33342 (Beyotime, Nantong, China), according to the
manufacturer’s protocol. Staining was visualized using a ﬂuores-
cence microscope with excitation at 350 nm and measurement at
460 nm. Each assay was performed in triplicate and repeated three
times independently.
2.8. Apoptosis analysis: TUNEL assay
GES-1 cells (3105 cells/well) were seeded onto dedicated
slides and cultured at 37 °C for 24 h. Cells were treated with
100 μM H2O2 for 6 h, and then ﬁxed with 4% paraformaldehyde.
The terminal nucleotidyl transferase-mediated nick end labeling
(TUNEL) assay was performed using the In Situ Cell Death Detec-
tion Kit, Fluorescein (Roche, Basel, Switzerland) following the
manufacturer’s instructions. After ﬁnal washes with PBS, slides
were mounted using an anti-fade mounting solution containing
DAPI (Vector, Burlingame, CA, USA). Slides were analyzed and
imaged using a ﬂuorescence microscope. We calculated the aver-
age of three randomly selected visual ﬁelds and repeated analyses
three times independently.
2.9. Nuclear-cytoplasmic and mitochondria fractionation
Nuclear-cytoplasmic and mitochondria fractions were obtained
using the Nuclear and Cytoplasmic Protein Extraction and Cell
Mitochondria Isolation Kits (Beyotime, Shanghai, China), respec-
tively, according to the manufacturer’s protocols.
2.10. Western blotting
Cells were digested in RIPA buffer in the presence of Protease
Inhibitor Cocktail (Pierce, Appleton, WI, USA). Protein was quan-
tiﬁed using a BCA Protein Assay Kit (Pierce). Protein (30 μg) was
separated by 10% sodium dodecyl sulfate polyacrylamide gel
electrophoresis, and transferred onto polyvinylidene ﬂuoride
membranes. Membranes were blocked with 5% non-fat milk in
Tris-buffered saline (TBS) and then incubated with primary anti-
bodies at 4 °C overnight. The primary antibodies used were mouse
anti-ALDH2 (1:1000; Cat. #AM1831a, ABGENT, San Diego, CA,
USA), mouse anti-β-Tubulin (1:1000; Cat. T4026, Sigma, St. Louis,
MO, USA), rabbit anti-COX IV (1:1000; Cat. #4850, Cell Signaling
Technology, Danvers, MA, USA), goat anti-Lamin B (1:1000; Cat. sc-
6216, Santa Cruz, Dallas, Texas, USA), rabbit anti-cleaved-caspase-3
(1:1000; Cat. #9661, Cell Signaling Technology), rabbit anti-
cleaved-caspase-9 (1:1000; Cat. #9502, Cell Signaling Technology),
rabbit anti-phospho-p53 (Ser15) (1:1000; Cat. #9284, Cell Signal-
ing Technology), rabbit anti-4-HNE (1:1000; Cat. #ab46545, Ab-
cam, Cambridge, MA, USA), rabbit anti-phospho-H2AX (Ser139)
(1:1000; Cat. #9718, Cell Signaling Technology), rabbit anti-phos-
pho-ATM (Ser1981) (1:1000; Cat. #ab81292, Abcam), rabbit anti-
β-actin, and horseradish peroxidase-linked primary antibody
(1:4000; Cat. #PM053-7, MBL, Beijing, China). Membranes were
then washed three times in TBS with 0.05% Tween-20 for 10 min
each time, followed by incubation with goat anti-rabbit IgG
horseradish peroxidase-conjugated secondary antibody (1:2000;
Cat. #7074, Cell Signaling Technology) or horse anti-mouse IgGhorseradish peroxidase-conjugated secondary antibody (1:2000;
Cat. #7074, Cell Signaling Technology) for 1 h at room tempera-
ture. Signals were detected by a SuperSignal West Pico Chemilu-
minescent Substrate kit (Pierce, Rockford, IL, USA) according to the
manufacturer’s instructions.
2.11. GSH and GSSG measurements
Reduced (GSH) and oxidized (GSSG) glutathione levels were
determined using the GSH/GSSG-412 assay kit (Percipio Bios-
ciences) according to the manufacturer’s instructions. Cells were
plated in 6-well cell culture plates at a density of 1105 cells/well
and allowed to adhere to the plate for 1 day prior to treatment
with 100 μM H2O2 or 10 μM 4-HNE for 6 h. After treatment, GES-1
cells were then harvested by trypsinization, resuspended in cell
culture media, and washed twice in ice-cold PBS. The level of re-
duced glutathione was calculated as the difference between levels
of total glutathione and oxidized glutathione, and the GSH:GSSG
ratio calculated. Each assay was performed using three biological
replicates of each treatment.
2.12. Statistical analyses
All data presented are representative of at least three in-
dependent experiments and expressed as the mean7standard
deviation (SD). The differences between groups were analyzed
using the Student’s t-test when there were only two groups, or
assessed by one-way ANOVA when there were more than two
groups. Two-way ANOVA was used for the analysis of multiple
comparisons and WST cell survival data. All statistical analyses
were performed using the SPSS 16.0 software. A two-tailed value
of po0.05 was considered to indicate a statistically signiﬁcant
difference.3. Results
3.1. 4-HNE is produced during lipid peroxidation in GES-1 cells
treated with H2O2
Increasing concentrations of H2O2 were added to the growth
media of GES-1 cells and trypan blue exclusion staining was used to
assess membrane damage after 6 h incubation. Greater than 80% of
cells excluded the dye at 1 μM H2O2 and more than 70% at 10 μM
(Fig. 1A). Signiﬁcant differences in dye exclusion between control and
experimental samples were apparent at and above H2O2 concentra-
tions of 100 μM. These ﬁndings indicate that the decreased cell via-
bility observed at 100 μM H2O2 and above is associated with acute
membrane damage. Measurement of lipid peroxidation using the
thiobarbituric acid-reactive substance assay revealed that lipid per-
oxidation was increased in H2O2-treated cells (Fig. 1B). Additionally,
increasing concentrations of H2O2 were associated with elevated
4-HNE levels compared with untreated control cells. These results
indicate that increased lipid peroxidation in H2O2-treated cells re-
sulted in a proportional increase in 4-HNE levels.
We next tested whether ALDH2 translocated to the extra-mi-
tochondrial spaces in GES-1 cells treated with H2O2. After treat-
ment of GES-1 cells with 100 μM H2O2, ALDH2 did not translocate
from the mitochondria to the cytosol or nucleus at any time point
examined (Fig. S1).
3.2. ALDH2 reduces oxidative stress-associated damage in GES-1
cells treated with H2O2
We next used retrovirus-based gene knockdown and over-
expression systems to generate ALDH2-knockdown GES-1 cells
Fig. 1. Effect of lipid peroxidation on GES-1 cells treated with H2O2. (A) GES-1 cells were incubated with increasing concentrations of H2O2 for 6 h and membrane integrity
was estimated by trypan blue exclusion staining. Data are shown as the mean7SD of three independent experiments (*po0.05, **po0.01, ***po0.001). (B) GES-1 cells
were incubated with increasing concentrations of H2O2 for 6 h and lipid peroxidation was determined using the Biotech LPO-586™ kit. The values of three independent
experiments (mean7SD) are presented (*po0.05, **po0.01, ***po0.001).
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overexpressing GES-1 cells (designated ALDH2) to examine the
biological functions of ALDH2 in gastric mucosal epithelial cells.
ALDH2 mRNA and protein levels were suppressed by greater than
90% of control levels in ALDH2-shRNA1 and ALDH2-shRNA2 cells,
while ALDH2-overexpressing cells had dramatically increased le-
vels of ALDH2 mRNA and protein compared with empty vector-
transduced (designated vector) cells (Fig. 2A and B).
GES-1 cells over- or underexpressing ALDH2 were next exposed
to increasing concentrations of H2O2 and collected after a 6-h in-
cubation for cell viability analysis. WST assay analysis revealed that
cell viability was reduced in ALDH2-shRNA1 (po0.01) and
ALDH2-shRNA2 (po0.05) cells compared with the control, while
ALDH2 overexpression enhanced cell viability (po0.01; Fig. 2C).
Additionally, Fig. S2 reveals that the viability of ALDH2-shRNA1
and ALDH2-shRNA2 cells was lower than that of control cells,
while ALDH2 cell viability was higher than the vector cells at the
concentrations of 1, 10, and 100 μM of H2O2.
Cellular morphology was observed by light microscopy (Nikon,
Japan) prior to cell counting (Fig. 2D). Next, trypan blue exclusion
staining was used for cell viability analysis. Viability of both
ALDH2-shRNA1 (39.3572.00%) and ALDH2-shRNA2 (40.817
1.88%) cells was lower than scramble cells (50.3773.41%; po0.01
and po0.05, respectively). Meanwhile, cell viability of ALDH2 was
higher than the vector (61.0773.98% vs. 47.3373.82%, po0.05;
Fig. 2E).
3.3. ALDH2 ameliorates apoptosis of GES-1 cells treated with H2O2
We next examined the effects of ALDH2 on apoptosis using
ﬂow cytometry, as apoptosis may be involved in the changes to
cell viability observed following treatment with H2O2. Following
treatment with 100 μM H2O2 for 6 h, apoptosis in ALDH2-shRNA1
(26.9672.41%) and ALDH2-shRNA2 (22.8373.28%) cells was in-
creased compared with that of control cells (14.0171.69%,
po0.01 and po0.05, respectively). Meanwhile, apoptosis was
signiﬁcantly decreased in ALDH2 compared with the control
(10.3571.49% vs. 15.4171.62%, po0.05; Fig. 3A and D). Ad-
ditionally, we also detected apoptosis at 0, 1, 3, and 6 h. The ﬂow
cytometry demonstrated that ALDH2 ameliorated cell apoptosis
induced by incubation with H2O2 (Fig. S3).
We also assessed apoptosis by detecting nuclear condensation
and DNA fragmentation by Hoechst 33342 staining andﬂuorescence microscopy. At least three randomly selected ﬁelds of
200 magniﬁcation were counted, and the average number of
apoptotic cells determined. ALDH2-shRNA1 and ALDH2-shRNA2
cells treated with H2O2 (100 μM) for 6 h exhibited many more
cells with condensed and fragmented nuclei than did scramble
cells (18.3371.53% and 16.3371.53% vs. 9.6771.53%; po0.01).
Similar results were obtained using TUNEL analysis (Fig. 3C and
F), with 12.6772.52% of ALDH2-shRNA1 and 9.6771.53% of
ALDH2-shRNA2 cells staining positive vs. 3.3371.53% of control
cells (po0.01). Additionally, ALDH2 cells treated with 100 μM of
H2O2 for 6 h showed predominantly decreased DNA fragmentation
and condensed nuclei compared with vector cells by Hoechst
33342 staining (5.3371.53% vs. 8.6771.15%, po0.05) and TUNEL
analysis (1.6770.58% vs. 4.3371.53%, po0.05; Fig. 3C–F).
3.4. ALDH2 reduces caspase activation in GES-1 cells treated with
H2O2
Caspases play a central role in the transduction of apoptotic
signals, so we next evaluated whether caspases were involved
with ALDH2-mediated regulation of apoptosis following treatment
of GES-1 cells with H2O2. Western blotting identiﬁed activation of
caspase-9 6 h following H2O2 treatment of GES-1 cells (Fig. 4A and
B). Furthermore, levels of cleaved caspase-9 and cleaved caspase-3
in both ALDH2-shRNA1 and ALDH2-shRNA2 cells were higher than
those of scramble cells 6 h after H2O2 treatment. Meanwhile, levels
of cleaved caspase-9 and cleaved caspase-3 in ALDH cells were less
than those of vector cells. We also detected levels of cleaved cas-
pase-9 and cleaved caspase-3 in ALDH2-shRNA1 and scramble
cells at 0, 1, 3, and 6 h. Levels of cleaved caspase-9 and cleaved
caspase-3 were higher in ALDH2-shRNA1 cells compared with
scramble cells (Fig. 4C and D).
3.5. ALDH2 protects GES-1 cells against DNA damage induced by
H2O2
We next evaluated the effect of under- and overexpression of
ALDH2 in GES-1 cells on H2O2-induced DNA damage by assessing
phosphorylation of ATM, p53, and H2AX by western blotting. Le-
vels of phosphorylated ATM, p53, and H2AX were greater in
ALDH2-shRNA1 and ALDH2-shRNA2 cells compared with scramble
cells 6 h after H2O2 treatment (Fig. 5A and B). Meanwhile, over-
expression of ALDH2 decreased the phosphorylation of ATM, p53,
Fig. 2. Effect of ALDH2 on the survival of GES-1 cells treated with H2O2. (A,B) Relative expression of ALDH2 in ALDH2-shRNA1- and ALDH2-shRNA2-expressing, and ALDH2-
overexpressing GES-1 cells as determined by qRT-PCR and western blotting. Data presented are the mean7SD of three independent experiments (**po0.01, ***po0.001).
(C) WST assay using scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2 GES-1 cells treated with increasing concentrations of H2O2 for 6 h. Data presented are
from three independent experiments (*po0.05, **po0.01). (D) Cell morphology of scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2 GES-1 cells treated with
100 μM H2O2. Original magniﬁcation: 100 . (E) Cell viability analysis of cells stained using trypan blue and assessed using a cell viability analyzer (*po0.05, **po0.01).
Data presented are the mean7SD of three independent experiments.
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Fig. 3. Overexpression of ALDH2 suppresses apoptosis of GES-1 cells treated with H2O2. (A) Representative histograms depicting apoptosis of scramble, ALDH2-shRNA1,
ALDH2-shRNA2, vector, and ALDH2 GES-1 cells treated with 100 μMH2O2. (B) Representative histograms depicting nuclear morphology of scramble, ALDH2-shRNA1, ALDH2-
shRNA2, vector, and ALDH2 GES-1 cells treated with 100 μM H2O2 (Hoechst 33342 staining, original magniﬁcation 200 ). (C) Apoptosis of scramble, ALDH2-shRNA1,
ALDH2-shRNA2, vector, and ALDH2 GES-1 cells treated with 100 μM H2O2 as determined by TUNEL (original magniﬁcation 200 ). (D–F) Histograms depicting the pro-
portion of apoptotic cells as determined by ﬂow cytometry (D) Hoechst 33342 (E), and TUNEL (F). Data presented are the mean7SD of three independent experiments
(*po0.05, **po0.01).
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Fig. 4. Apoptosis-associated protein assay of GES-1 cells treated with H2O2. (A,B) Immunoblotting of cleaved caspase-9 and caspase-3 protein levels in scramble, ALDH2-
shRNA1, ALDH2-shRNA2, vector, and ALDH2 GES-1 cells following 6 h treatment with 100 μM H2O2. Data presented are the mean7SD of three independent experiments
(*po0.05, **po0.01). (C,D) Immunoblotting of cleaved caspase-9 and caspase-3 protein levels in scramble and ALDH2-shRNA1 GES-1 cells following 100 μMH2O2 treatment
for 0, 1, 3, and 6 h. Data presented are the mean7SD of three independent experiments (*po0.05, **po0.01, ***po0.001). Protein levels were normalized to those of β-
actin. Immunoblots shown are representative of three independent experiments.
Fig. 5. ALDH2 protects GES-1 cells from DNA damage induced by H2O2. (A,B) Immunoblotting of phospho-ATM (ser1981), phospho-H2AX (ser139), and phospho-p53 (ser15)
protein levels in scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2 GES1 cells following 6 h treatment with 100 μM H2O2. Data presented are the mean7SD of
three independent experiments (*po0.05, **po0.01). (C) Immunoblotting of phospho-ATM (ser1981), phospho-H2AX (ser139), and phospho-p53 (ser15) in scramble and
ALDH2-shRNA1 GES-1 cells following treatment with 100 μM H2O2 for 0, 1, 3, and 6 h. Protein levels were normalized to those of β-actin. Results shown are representative of
three independent experiments.
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Fig. 6. ALDH2 protects GES-1 cells from DNA damage following treatment with 4-HNE. (A) Immunoblotting of 4-HNE levels in scramble, ALDH2-shRNA1, ALDH2-shRNA2,
vector, and ALDH2 GES-1 cells following treatment with 100 μM H2O2 for 6 h. (B) Immunoblotting of 4-HNE levels in scramble and ALDH2-shRNA1 GES-1 cells following
treatment with 100 μM H2O2 for 0, 1, 3, and 6 h. (C) Cell viability assay using scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2 GES-1 cells treated with
increasing concentrations of 4-HNE for 6 h. Data presented are the mean7SD of three independent experiments (**po0.01, ***po0.001). (D) Immunoblotting of cleaved
caspase-9 and caspase-3 levels in scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2 GES-1 cells following treatment with 10 μM 4-HNE for 6 h.
(E) Immunoblotting of phospho-ATM (ser1981), phospho-H2AX (ser139), and phospho-p53 (ser15) levels in scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2
GES-1 cells following treatment with 10 μM 4-HNE for 6 h. Protein levels were normalized to those of β-actin. Results shown are representative of three independent
experiments.
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sessed ALDH2-shRNA1 and scramble cells at 0, 1, 3, and 6 h after
H2O2 treatment and found that phosphorylation of ATM, p53, and
H2AX was higher in ALDH2-shRNA1 cells compared with scramble
cells (Fig. 5C).3.6. 4-HNE mediates H2O2-induced DNA damage in GES-1 cells
Loss of ALDH2 function can lead to elevated levels of 4-HNE
and other aldehydes, so we measured 4-HNE in GES-1 cells treated
with 100 μM H2O2. Levels of 4-HNE were increased in ALDH2-
shRNA1 and ALDH2-shRNA2 cells 6 h after H2O2 treatment when
Y. Duan et al. / Free Radical Biology and Medicine 93 (2016) 165–176 173compared with scramble cells (Fig. 6A). Meanwhile, 4-HNE was
decreased in ALDH2 cells compared with vector cells (Fig. 6A). We
then measured 4-HNE levels in ALDH2-shRNA1 and scramble cells
at 0, 1, 3, and 6 h after H2O2 treatment and detected increased
4-HNE in ALDH2-shRNA1 cells compared with scramble cells
(Fig. 6B). We also detected the ﬁnal concentration of 4-HNE in
scramble and ALDH2-shRNA1 GES-1 cells following treatment
with 1 or 10 μM 4-HNE for 6 h. The proportions of 4-HNE meta-
bolized by mitochondrial ALDH2 were 56.33710.12% and
34.3379.29% in ALDH2-shRNA1 cells treated with 1 and 10 μM
4-HNE, respectively. The reduced proportion of 4-HNE metabo-
lized most likely results from inactivation of ALDH2, consistent
with a previous report [8].
We next investigated the relationship between ALDH2 and cellFig. 7. Effect of H2O2 and 4-HNE on the GSH:GSSG ratio in GES-1 cells. (A–C) Levels of GS
vector, and ALDH2 GES-1 cells without H2O2 or 4-HNE treatment. Data are presented as th
the GSH:GSSG ratio, in scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2 G
independent experiments (*po0.05, **po0.01). (G–I) Levels of GSH and GSSG, and the
GES-1 cells treated with 10 μM 4-HNE. Data are presented as the mean7SD of three inviability following treatment with 4-HNE by exposing GES-1 cells
to different concentrations of 4-HNE for 6 h followed by cell via-
bility analysis. Both ALDH2-shRNA1 (po0.001 ) and ALDH2-
shRNA2 (po0.01) cells had reduced viability compared with
control cells, while ALDH2 overexpression enhanced cell viability
(po0.01; Fig. 6C). The viability of ALDH2-shRNA1 and ALDH2-
shRNA2 cells was lower than that of control cells, while ALDH2 cell
viability was higher than that of vector cells following treatment
with 5, 10, or 50 μM 4-HNE (Fig. S4).
We also assessed apoptosis and DNA damage in GES-1 cells
treated with 10 μM 4-HNE. Levels of cleaved caspase-9 and
cleaved caspase-3 were increased in ALDH2-shRNA1 and ALDH2-
shRNA2 cells 6 h after treatment with 4-HNE when compared with
scramble cells (Fig. 6D). Meanwhile, levels of cleaved caspase-9H and GSSG, and the GSH:GSSG ratio, in scramble, ALDH2-shRNA1, ALDH2-shRNA2,
e mean7SD of three independent experiments. (D–F) Levels of GSH and GSSG, and
ES1 cells treated with 100 μM H2O2. Data presented are the mean7SD of three
GSH:GSSG ratio, in scramble, ALDH2-shRNA1, ALDH2-shRNA2, vector, and ALDH2
dependent experiments (*po0.05, **po0.01).
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with vector cells (Fig. 6D). Similarly, phosphorylation of ATM, p53,
and H2AX was increased in ALDH2-shRNA1 and ALDH2-shRNA2
cells compared with scramble cells 6 h after 4-HNE treatment
(Fig. 6E). Additionally, overexpression of ALDH2 decreased phos-
phorylation of ATM, p53, and H2AX 6 h after 4-HNE treatment
(Fig. 6E). We also assessed DNA damage marker expression in GES-
1 cells treated with 10 μM 4-HNE at 0, 5, 10, 30, and 60 min time
points. Phosphorylation of ATM occurred prior to the phosphor-
ylation of H2AX and p53 (Fig. S5). This suggests that H2AX and
p53 play important roles as downstream targets of ATM, con-
sistent with previous reports [18,19].
3.7. ALDH2 modulates the redox status of GES-1 cells treated with
H2O2 and 4-HNE
When mammalian cells are exposed to increased oxidative
stress, the ratio of GSH:GSSG decreases as a consequence of GSSG
accumulation. Measurement of the GSSG level or determination of
the GSH:GSSG ratio indicates the extent of oxidative stress and can
be used to monitor the effectiveness of antioxidant intervention
strategies. ALDH2-shRNA1, ALDH2-shRNA2, ALDH2, and vector
cells exhibited no differences in GSH, GSSG, or GSH:GSSG ratio in
the absence of H2O2 or 4-HNE (Fig. 7A–C). Treatment with 100 μM
H2O2 or 10 μM 4-HNE induced a signiﬁcant decrease in GSH levels
in both ALDH2-shRNA1 and ALDH2-shRNA2 cells compared with
control cells, while ALDH2 overexpression promoted GSH levels
(Fig. 7D and G). However, treatment with 100 μM H2O2 or 10 μM
4-HNE led to a signiﬁcant increase in GSSG levels in ALDH2-
shRNA1 and ALDH2-shRNA2 cells compared with control cells,
while GSSG levels were reduced in ALDH2-overexpressing cells
(Fig. 7E and H). Treatment with 100 μM H2O2 or 10 μM 4-HNE
induced a signiﬁcant decrease in the GSH:GSSG ratio in both
ALDH2-shRNA1 and ALDH2-shRNA2 cells compared with control
cells, while the GSH:GSSG ratio was increased in ALDH2-over-
expressing cells (Fig. 7F and I).Fig. 8. Schematic depiction of ALDH2 functions in protecting gastric mucosa from
oxidative stress. H2O2 as a source of extracellular ROS can induce oxidative stress.
High levels of ROS can oxidize lipids present within cell membranes to generate
4-HNE, leading to DNA damage. Under normal physiological conditions, 4-HNE can
be cleared by ALDH2. However, the level of 4-HNE is elevated signiﬁcantly in in-
dividuals with inactivated ALDH2. Here, 4-HNE causes DNA damage and initiates
apoptosis with elevated phospho-ATM (ser1981), phospho-H2AX (ser139), and
phospho-p53 (ser15). Therefore, ALDH2 protects gastric mucosa cells against DNA
damage induced by oxidative stress.4. Discussion
Oxidative stress is deﬁned as an imbalance between oxidants
and antioxidants in favor of the oxidants, which leads to disrup-
tion of redox signaling and molecular damage [20]. Roles for free
radicals and ROS have been described in multiple pathophysiolo-
gical processes including aging, degenerative diseases, and carci-
nogenesis [21]. Oxygen toxicity is not only restricted to hyperbaric
oxygen, but also involves the stress induced by oxygen metabo-
lites. The superoxide anion radical, hydrogen peroxide, and the
extremely reactive hydroxyl radical are common products of life in
an aerobic environment, and these agents appear responsible for
oxygen toxicity [22]. Hydrogen peroxide may also induce the self-
generation of free radicals, or ROS-induced ROS release, which
further exacerbates oxidative stress [23]. We studied the role of
ALDH2 in protecting cells from oxidative damage by using GES-1
cells treated with H2O2 as a model of oxidative stress Fig. 8.
We found that H2O2 could induce acute cell membrane da-
mage, and that 4-HNE was produced during lipid peroxidation in
GES-1 cells treated with H2O2. Increased levels of ALDH2 sig-
niﬁcantly attenuated this H2O2-induced cell damage, facilitating
increased cell viability and reduced apoptosis of GES-1 cells. Upon
initiation of apoptosis, cytochrome c released from the mi-
tochondria associates with and mediates activation of caspase-9,
resulting in cleavage at Asp315 and production of a p35 subunit
[24]. Additional cleavage occurs at Asp330, producing a p37 sub-
unit that can amplify the apoptotic response. Cleaved caspase-9
further processes other caspase members, including caspase-3,driving a caspase cascade that leads to apoptosis [25]. Activation of
caspase-3 requires proteolytic processing of its inactive zymogen
into activated p17 and p12 fragments [26]. We treated GES-1 cells
with H2O2 and found that the presence of ALDH2 reduces the level
of cleaved caspase-9 and cleaved caspase-3 to protect from
apoptosis. This blockage of H2O2-induced apoptosis by ALDH2 may
be mediated by an increase in antioxidant capacity, and/or the
prevention of accumulation of oxygen metabolites during oxida-
tive stress.
ROS-mediated DNA damage may participate in carcinogenesis,
and oxidative stress-induced modiﬁcations to DNA bases have
been ascribed much importance [27]. The mechanisms of cell
protection against such DNA damage include the combined actions
of DNA repair and detoxiﬁcation by multiple enzymes. ATM kinase
can phosphorylate multiple substrates on either serine or threo-
nine residues in response to DNA damage. Initiation of the DNA
damage response is associated with p53 activation by ATM [18].
Phosphorylation of p53 reduces its interaction with the negative
regulator MDM2, promoting both the accumulation and activation
of p53 in response to DNA damage [28]. Additionally, an early step
in the DNA damage response is phosphorylation of histone H2AX
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H2AX at sites of DNA damage [19,29]. We found that ALDH2
protects GES-1 cells from ROS-mediated DNA damage by detecting
the phosphorylation levels of ATM (Ser1981), H2AX (Ser139), and
p53 (Ser15).
Because of their high chemical reactivity, aldehydes are con-
sidered to act as second messengers of oxidative stress. Aldehydes
originate from free radical-induced oxidation reactions of lipid
structures and can bind to DNA to promote potentially mutagenic
and carcinogenic changes [30]. Additionally, 4-HNE–DNA adducts
can also induce frameshift and base-pair substitution mutations.
Such 4-HNE-induced mutations have been detected in a number of
tissues, including the liver, breast, white blood cells, pancreas,
colon, and gastric mucosa [31–33]. A decrease in ALDH2 activity
impairs cellular detoxiﬁcation and promotes DNA damage [34].
Furthermore, endogenous reactive aldehydes can damage DNA in
hematopoietic stem cells, while ALDH2 counteracts this threat to
exert protective effects [35]. We also found ALDH2 protected GES-
1 cells from DNA damage induced by aldehyde metabolism. In this
study, we used the LPO-586™ assay to illustrate that 4-HNE was
produced following lipid peroxidation. However, a limitation of
the assay is that not only 4-HNE but also other aldehydes can be
detected.
GSH can be oxidized to form GSSG when mammalian cells are
exposed to increased oxidative stress, and this process plays a vital
role in maintaining the cellular redox balance. Therefore, mea-
surement of the GSSG level or determination of the GSH:GSSG
ratio is a useful indicator of oxidative stress [36]. We found that
ALDH2 could preserve cellular GSH levels when GES-1 cells were
treated with H2O2 or 4-HNE. This effect may function to protect
cells from redox imbalances and thereby limit oxidative stress-
related pathologies. Our ﬁndings show that ALDH2 can protect
gastric mucosal cells against DNA damage induced by oxidative
stress, and further suggest that ALDH2 exerts this protective role
through metabolizing aldehydes generated by oxidative stress.
ALDH2 is best known as an aldehyde-detoxifying enzyme.
Approximately 40% of the East-Asian population carry the
ALDH2*2 mutant allele, which has signiﬁcantly reduced enzymatic
activity when compared with the wild-type allele ALDH2*1 [37]. A
single nucleotide substitution (G–A) in exon 12 leads to a gluta-
mate–lysine mutation at position 487 [38]. This single amino acid
change leaves heterozygous individuals with approximately 6% of
the wild-type enzymatic activity, while homozygous individuals
possess almost no ALDH2 activity [39]. This reduction in enzy-
matic activity further weakens the protective effect of ALDH2 on
the gastric mucosa [40]. Therefore, the gastric mucosa is prone to
irreversible DNA damage in ALDH2*2 individuals and this may be
one reason for the higher incidence of gastric cancer in East-Asian
populations.
We have characterized a protective role for ALDH2 in gastric
mucosa cells. ALDH2 protects gastric mucosa cells against DNA
damage induced by 4-HNE aldehydes generated during oxidative
stress. Since DNA damage is irreversible in gastric mucosa cells,
the antioxidative effects of ALDH2 may be important for protecting
the gastric mucosa from oxidative stress.Conﬂict of interest statement
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